413 related articles for article (PubMed ID: 19699150)
1. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons.
Reeves WH; Lee PY; Weinstein JS; Satoh M; Lu L
Trends Immunol; 2009 Sep; 30(9):455-64. PubMed ID: 19699150
[TBL] [Abstract][Full Text] [Related]
2. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus.
Lee PY; Kumagai Y; Li Y; Takeuchi O; Yoshida H; Weinstein J; Kellner ES; Nacionales D; Barker T; Kelly-Scumpia K; van Rooijen N; Kumar H; Kawai T; Satoh M; Akira S; Reeves WH
J Exp Med; 2008 Dec; 205(13):2995-3006. PubMed ID: 19047436
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of autoantibody production in pristane-induced murine lupus.
Han S; Zhuang H; Xu Y; Lee P; Li Y; Wilson JC; Vidal O; Choi HS; Sun Y; Yang LJ; Reeves WH
Arthritis Res Ther; 2015 Dec; 17():384. PubMed ID: 26717913
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of the type I interferon receptor protects mice from experimental lupus.
Nacionales DC; Kelly-Scumpia KM; Lee PY; Weinstein JS; Lyons R; Sobel E; Satoh M; Reeves WH
Arthritis Rheum; 2007 Nov; 56(11):3770-83. PubMed ID: 17968932
[TBL] [Abstract][Full Text] [Related]
5. A novel type I IFN-producing cell subset in murine lupus.
Lee PY; Weinstein JS; Nacionales DC; Scumpia PO; Li Y; Butfiloski E; van Rooijen N; Moldawer L; Satoh M; Reeves WH
J Immunol; 2008 Apr; 180(7):5101-8. PubMed ID: 18354236
[TBL] [Abstract][Full Text] [Related]
6. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
[TBL] [Abstract][Full Text] [Related]
7. Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon.
Shao WH; Shu DH; Zhen Y; Hilliard B; Priest SO; Cesaroni M; Ting JP; Cohen PL
Arthritis Rheumatol; 2016 Nov; 68(11):2697-2707. PubMed ID: 27110677
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.
Xu Y; Lee PY; Li Y; Liu C; Zhuang H; Han S; Nacionales DC; Weinstein J; Mathews CE; Moldawer LL; Li SW; Satoh M; Yang LJ; Reeves WH
J Immunol; 2012 Apr; 188(8):4113-21. PubMed ID: 22422888
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.
Xu Y; Zhuang H; Han S; Liu C; Wang H; Mathews CE; Massini J; Yang L; Reeves WH
Arthritis Rheumatol; 2015 Jan; 67(1):225-37. PubMed ID: 25252121
[TBL] [Abstract][Full Text] [Related]
10. Interferon Lambda Regulates Cellular and Humoral Immunity in Pristane-Induced Lupus.
Aschman T; Schaffer S; Biniaris Georgallis SI; Triantafyllopoulou A; Staeheli P; Voll RE
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769174
[TBL] [Abstract][Full Text] [Related]
11. TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus.
Bossaller L; Christ A; Pelka K; Nündel K; Chiang PI; Pang C; Mishra N; Busto P; Bonegio RG; Schmidt RE; Latz E; Marshak-Rothstein A
J Immunol; 2016 Aug; 197(4):1044-53. PubMed ID: 27354219
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
13. X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus.
Satoh M; Mizutani A; Behney KM; Kuroda Y; Akaogi J; Yoshida H; Nacionales DC; Hirakata M; Ono N; Reeves WH
Int Immunol; 2003 Sep; 15(9):1117-24. PubMed ID: 12917264
[TBL] [Abstract][Full Text] [Related]
14. An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage.
Kahlenberg JM; Yalavarthi S; Zhao W; Hodgin JB; Reed TJ; Tsuji NM; Kaplan MJ
Arthritis Rheumatol; 2014 Jan; 66(1):152-62. PubMed ID: 24449582
[TBL] [Abstract][Full Text] [Related]
15. Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane).
Nacionales DC; Kelly KM; Lee PY; Zhuang H; Li Y; Weinstein JS; Sobel E; Kuroda Y; Akaogi J; Satoh M; Reeves WH
Am J Pathol; 2006 Apr; 168(4):1227-40. PubMed ID: 16565497
[TBL] [Abstract][Full Text] [Related]
16. Pristane-induced lupus: considerations on this experimental model.
Freitas EC; de Oliveira MS; Monticielo OA
Clin Rheumatol; 2017 Nov; 36(11):2403-2414. PubMed ID: 28879482
[TBL] [Abstract][Full Text] [Related]
17. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH
Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432
[TBL] [Abstract][Full Text] [Related]
18. TLR7-Mediated Lupus Nephritis Is Independent of Type I IFN Signaling.
Wolf SJ; Theros J; Reed TJ; Liu J; Grigorova IL; Martínez-Colón G; Jacob CO; Hodgin JB; Kahlenberg JM
J Immunol; 2018 Jul; 201(2):393-405. PubMed ID: 29884703
[TBL] [Abstract][Full Text] [Related]
19. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
Chasset F; Ribi C; Trendelenburg M; Huynh-Do U; Roux-Lombard P; Courvoisier DS; Chizzolini C;
Rheumatology (Oxford); 2020 Nov; 59(11):3468-3478. PubMed ID: 32375176
[TBL] [Abstract][Full Text] [Related]
20. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
